Biotechnology Bears are Losing Control Over Amicus Therapeutics (FOLD), Here’s Why It’s a ‘Buy’ Now May 5, 2022
Biotechnology BioMarin to Present Findings from Ongoing Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the World Federation of Hemophilia 2022 World Congress, May 8-11, 2022, Including Five Platform Presentations May 5, 2022
Biotechnology BridgeBio Pharma Reports First Quarter 2022 Financial Results and Business Update May 5, 2022
Biotechnology argenx Reports First Quarter 2022 Financial Results and Provides Business Update May 5, 2022
Biotechnology argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia May 5, 2022
Search
Biotechnology
